| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
642 |
478 |
$960K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,658 |
1,492 |
$91K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,250 |
889 |
$51K |
| 99215 |
Prolong outpt/office vis |
243 |
210 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41 |
37 |
$992.14 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
205 |
177 |
$974.37 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
12 |
$723.94 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
136 |
119 |
$642.70 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
115 |
106 |
$177.33 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
35 |
24 |
$43.56 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
14 |
13 |
$0.00 |